These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 36523682)
1. Differentiating Immune-Related Adrenal Insufficiency From Low Cardiac Output Syndrome: A Case Report. Tanabe J; Watanabe N; Ito M; Kanasaki K; Tanabe K Cureus; 2022 Nov; 14(11):e31349. PubMed ID: 36523682 [TBL] [Abstract][Full Text] [Related]
2. Isolated Adrenocorticotropic Hormone (ACTH) Deficiency as an Immune-Related Adverse Event Following Combination Immune Checkpoint Inhibitor Therapy. Matsushiro M; Shibue K; Osawa K; Hamasaki A Cureus; 2024 Jun; 16(6):e62863. PubMed ID: 39040756 [TBL] [Abstract][Full Text] [Related]
3. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases]. Gu YC; Liu Y; Xie C; Cao BS Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206 [TBL] [Abstract][Full Text] [Related]
4. Pembrolizumab-induced secondary adrenal insufficiency due to adrenocorticotrophic hormone deficiency in a patient with non-small-cell lung carcinoma: a case report. Fujimiya T; Azuma K; Togashi Y; Kuwata K; Unezaki S; Takeuchi H J Pharm Health Care Sci; 2024 Feb; 10(1):10. PubMed ID: 38365819 [TBL] [Abstract][Full Text] [Related]
5. Isolated ACTH deficiency during single-agent pembrolizumab for squamous cell lung carcinoma: a case report. Tanaka S; Kushimoto M; Nishizawa T; Takubo M; Mitsuke K; Ikeda J; Fujishiro M; Ogawa K; Tsujino I; Suzuki Y; Abe M Clin Diabetes Endocrinol; 2020; 6():1. PubMed ID: 31921440 [TBL] [Abstract][Full Text] [Related]
6. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature. Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965 [TBL] [Abstract][Full Text] [Related]
7. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review. Lin SH; Zhang A; Li LZ; Zhao LC; Wu LX; Fang CT BMC Endocr Disord; 2022 Sep; 22(1):239. PubMed ID: 36153581 [TBL] [Abstract][Full Text] [Related]
8. Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review. Hinata Y; Ohara N; Sakurai Y; Koda R; Yoneoka Y; Takada T; Hara N; Nishiyama T Am J Case Rep; 2021 Jul; 22():e931639. PubMed ID: 34262010 [TBL] [Abstract][Full Text] [Related]
9. A case of secondary adrenocortical insufficiency due to isolated adrenocorticotropic hormone deficiency with empty sella syndrome after pembrolizumab treatment in a patient with metastatic renal pelvic cancer. Nagai T; Mogami T; Takeda T; Tomiyama N; Yasui T Urol Case Rep; 2021 Nov; 39():101766. PubMed ID: 34285878 [TBL] [Abstract][Full Text] [Related]
10. Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review. Oğuz SH; Ünlütürk U; Aksoy S; Erbas T Immunotherapy; 2021 Oct; 13(14):1157-1163. PubMed ID: 34387129 [TBL] [Abstract][Full Text] [Related]
11. Cardiomyopathy Associated With Tertiary Adrenal Insufficiency Manifesting as Refractory Heart Failure, Shock, and Sudden Cardiac Death: A Case Report. Wang X; Luo Y; Feng J Front Cardiovasc Med; 2021; 8():720154. PubMed ID: 34790704 [TBL] [Abstract][Full Text] [Related]
12. Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma. Ariyasu H; Inaba H; Ota T; Yamaoka H; Furukawa Y; Iwakura H; Doi N; Yamamoto Y; Akamizu T In Vivo; 2018; 32(2):345-351. PubMed ID: 29475919 [TBL] [Abstract][Full Text] [Related]
13. A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency. Sato Y; Tanaka Y; Hino M; Seike M; Gemma A Respir Med Case Rep; 2019; 26():223-226. PubMed ID: 30740300 [TBL] [Abstract][Full Text] [Related]
14. Pembrolizumab- and ipilimumab-induced diabetic ketoacidosis and isolated adrenocorticotropic hormone deficiency: a case report. Porntharukchareon T; Tontivuthikul B; Sintawichai N; Srichomkwun P J Med Case Rep; 2020 Sep; 14(1):171. PubMed ID: 32988414 [TBL] [Abstract][Full Text] [Related]
15. Multiple endocrinopathies, hypercalcaemia and pancreatitis following combined immune checkpoint inhibitor use- case report and review of literature. Newman C; Kgosidalwa O; Hakami OA; Kennedy C; Grogan L; Agha A BMC Endocr Disord; 2021 Feb; 21(1):33. PubMed ID: 33639911 [TBL] [Abstract][Full Text] [Related]
16. A Case of Nonsmall-Cell Lung Cancer with Anaphylaxis after 41 Courses of Pembrolizumab along with Adrenal Insufficiency as an Immune-Related Adverse Event. Nakamura T; Imai R; Nishimura N Case Rep Oncol; 2022; 15(3):804-808. PubMed ID: 36825102 [TBL] [Abstract][Full Text] [Related]
17. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report. Takeno A; Yamamoto M; Morita M; Tanaka S; Kanazawa I; Yamauchi M; Kaneko S; Sugimoto T BMC Endocr Disord; 2019 Feb; 19(1):25. PubMed ID: 30782163 [TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufficiency. Manaka K; Sato J; Takeuchi M; Watanabe K; Kage H; Kawai T; Sato Y; Miyagawa T; Yamada D; Kume H; Sato S; Nagase T; Iiri T; Nangaku M; Makita N Sci Rep; 2021 Jun; 11(1):11617. PubMed ID: 34078988 [TBL] [Abstract][Full Text] [Related]
19. Pembrolizumab-Induced Hypophysitis With Isolated Adrenocorticotropic Hormone (ACTH) Deficiency: A Rare Immune-Mediated Adverse Event. Doodnauth AV; Klar M; Mulatu YS; Malik ZR; Patel KH; McFarlane SI Cureus; 2021 Jun; 13(6):e15465. PubMed ID: 34123679 [TBL] [Abstract][Full Text] [Related]